11 . 06 .2026
Press release
Galderma unveils new global survey data exploring the evolving expectations and experiences of patients and healthcare professionals with anti-wrinkle treatments
22 . 05 .2026
Press release
Galderma receives U.S. FDA approval for Differin® Epiduo® Acne Gel Prescription-to-OTC switch
24 . 04 .2026
News story
Understanding connections across inflammatory skin conditions: the SKIN approach
23 . 04 .2026
Press release
Galderma reports strong start to the year, delivering first quarter 2026 net sales of 1.473 billion USD, growing 25.5% at constant currency
22 . 04 .2026
Press release
Galderma shareholders approve all Annual General Meeting proposals
16 . 04 .2026
Press release
Galderma launches new Alastin Regenerating Skin Nectar with TriHex+™, powered by its next-generation TriHex Technology® regenerative platform
09 . 04 .2026
Press release
Interim data from two ongoing investigator-initiated trials highlight the role of Sculptra® and Restylane® in addressing aesthetic changes associated with weight loss medications and menopause
07 . 04 .2026
Press release
Galderma debuts ALASTIN Signature Practices in partnership with leading aesthetic practices to elevate regenerative, peri-procedural skincare